New Chairman of KPMA Stresses on R&D Investments and Activities

Published: 2005-03-15 06:56:00

Updated: 2005-03-15 06:56:00

The newly appointed Chairman Huh Il-sup of the Korea Pharmaceutical Manufacturers Association (KPMA) expressed in the interview held last week that, under his new leadership, KPMA will continue to focus on promoting an efficient R&D investment by both the government and the pharmaceutical firms.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK